International Patent: HIGH-AFFINITY HUMAN ANTI-ACP3 ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE

GENEVA, Sept. 24 -- PHILOGEN S.P.A. filed a patent application (EP2026/056882) for “HIGH-AFFINITY HUMAN ANTI-ACP3 ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE”. With publication no. WO/2026/195461, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/40

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....